Satellos Bioscience Inc Com V.ICO

RE:RE:RE:RE:Bertilimumab Fast Tracked!

[Dandy07]

Immune was delisted from the Nasdaq which probably would have attracted a broader range of investors, but they are still trading on the OTC Market, which is still in New York. Having said that they still have a lot going for them despite being delisted, poor performing stock price, low market cap, and cash burn. .  Will they survive? I can bet they will.  They have a manufacturing parnter WuXi Biologics, and more results are coming with both licenced drugs!  so unless they are total failures or parameters changed during clinical trials, which can happen, I think they will pull through.  I did experience that with Bellus Health Inc.  They were even on a phase 3/4 confirmation study,  and yet some how still didn't make it - almost two years ago now a treatment for AA Amyloidosis - That's the risk you take with Biotechs.  Actually upon writing this i just discoverd a corprate update which should give everyone insight to iCO's partner - check it out its got some good and looking forward news.  Immune might even one day get back on the nasdaq. Again with any biotech or small caps, Time will tell.  I am not invested in Immune, just iCO.

https://ir.immunepharma.com/press-releases/detail/169/immune-pharmaceuticals-provides-a-corporate-update